Azacitidine (Intaza, Azacitidine Accord)
Azacitidine
Accord Healthcare (Pty) Ltd
Registration
- Applicant
- Accord Healthcare (Pty) Ltd
- Certificate holder
- Accord Healthcare (Pty) Ltd
- Registrations
- 3
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Intaza EACH VIAL CONTAINS: AZACITIDINE 100, 0 mg | 100 mgLyophilised powder for suspension for injection | 510453.45251/26/0453.452Approved 30 April 2026 | Registered | S4 | PIPIL |
| Azacitidine 150 MG accord Each vial contains: Azacitidine 150,0 mg | 150 mgPowder for suspension for injection) | 57048957/26/489Approved 7 July 2025 | Registered | S4 | PIPIL |
| Intaza 150 Each vial contains: Azacitidine 150,0 mg | 100 mgLyophilised powder for suspension for injection | 570490.048957/26/0490.489Approved 30 April 2026 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Azacitidine
S4: Azacitidine
Consolidated Schedules 06 July 2026, line 5405
Pharmacological class: Cytostatic agents (class 26)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
4-Amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one
Drag to rotate. Structure from PubChem CID 9444.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.